Search results
Found 2893 matches for
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
©
John Cairns
OVG Alumni
Browse the OVG Alumni, including those who have undertaken a PhD/DPhil, MSc or MD (a graduate degree in the UK for medical graduates) at OVG since 2001, with date of graduation and where available information on their current or most recent/notable role.
Research
The Oxford Vaccine Group conducts laboratory and clinical research in many different areas related to infectious diseases and vaccination in childhood as well as adulthood. Below you can browse all the different areas we investigate.
Study & Train @ OVG
We are committed to providing high quality education and training, together with research updates for medical professionals and all those involved in the area of vaccines and paediatric and adult infectious diseases.